Gibbs Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Buy
39,273
+21,065
+116% +$998K 0.19% 112
2025
Q4
$1.07M Sell
18,208
-3,531
-16% -$181K 0.26% 77
2025
Q3
$1.21M Sell
21,739
-2,360
-10% -$138K 0.27% 80
2025
Q2
$1.66M Sell
24,099
-3,167
-12% -$215K 0.32% 67
2025
Q1
$1.89M Sell
27,266
-453
-2% -$37.4K 0.46% 49
2024
Q4
$2.38M Buy
27,719
+4,616
+20% +$499K 0.65% 35
2024
Q3
$2.75M Buy
23,103
+2,875
+14% +$383K 0.89% 25
2024
Q2
$2.89M Buy
20,228
+5,615
+38% +$744K 1.17% 18
2024
Q1
$1.88M Buy
+14,613
New +$1.74M 1.08% 17

Other funds holding NVO